Evidence map›Paper›PMID 35727821›Full record

ArticlePLoS neglected tropical diseases2022

Evaluation of antibody serology to determine current helminth and Plasmodium falciparum infections in a co-endemic area in Southern Mozambique.

Rebeca Santano, Rocío Rubio, Berta Grau-Pujol, Valdemiro Escola, Osvaldo Muchisse, Inocência Cuamba, Marta Vidal, Gemma Ruiz-Olalla, Ruth Aguilar, Javier Gandasegui and 17 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. A Paired-Marker Framework for Interpreting Anti-Pathogens (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 12 institutions in 10 countries.

Rebeca SantanoISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.ORCID 0000-0002-0007-5315
Rocío RubioISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Berta Grau-PujolISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Valdemiro EscolaCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Osvaldo MuchisseCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Inocência CuambaCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Marta VidalISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Gemma Ruiz-OlallaISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Ruth AguilarISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Javier GandaseguiISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Maria DemontisDepartment of Parasitology, Centre of Infectious Diseases, Leiden University Medical Centre (LUMC), Leiden, The Netherlands.
Jose Carlos JamineCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Anélsio CossaCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Charfudin SacoorCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
Jorge CanoCommunicable and Non-communicable Diseases Cluster (UCN), WHO Regional Office for Africa, Brazzaville, Republic of Congo.
Luis IzquierdoISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Chetan E ChitnisMalaria Parasite Biology and Vaccines Unit, Department of Parasites and Insect Vectors, Institut Pasteur, Université de Paris, Paris, France.
Ross L CoppelDepartment of Microbiology, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
Virander ChauhanMalaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.
David CavanaghInstitute of Immunology and Infection Research, University of Edinburgh, Edinburgh, United Kingdom.
Sheetij DuttaWalter Reed Army Institute of Research (WRAIR), Silver Spring, Maryland, United States of America.
Evelina AngovWalter Reed Army Institute of Research (WRAIR), Silver Spring, Maryland, United States of America.
Lisette van LieshoutDepartment of Parasitology, Centre of Infectious Diseases, Leiden University Medical Centre (LUMC), Leiden, The Netherlands.
Bin ZhanBaylor College of Medicine (BCM), Houston, Texas, United States of America.
José MuñozISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Carlota DobañoISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Gemma MoncunillISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Barcelona Institute for Global Health · ESManhiça Health Research Centre · MZCentro de Investigación en Red en Enfermedades Cardiovasculares · ESLeiden University Medical Center · NLWalter Reed Army Institute of Research · USBaylor College of Medicine · USFundación Pro Salud y Medio Ambiente · ARInstitut Pasteur · FRInternational Centre for Genetic Engineering and Biotechnology · INMonash University · AUUniversity of Edinburgh · GBWorld Health Organization Regional Office for Africa · CG

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundSoil-transmitted helminths (STH), Schistosoma spp. and Plasmodium falciparum are parasites of major public health importance and co-endemic in many sub-Saharan African countries. Management of these infections requires detection and treatment of infected people and evaluation of large-scale measures implemented. Diagnostic tools are available but their low sensitivity, especially for low intensity helminth infections, leaves room for improvement. Antibody serology could be a useful approach thanks to its potential to detect both current infection and past exposure. METHODOLOGY: We evaluated total IgE responses and specific-IgG levels to 9 antigens from STH, 2 from Schistosoma spp., and 16 from P. falciparum, as potential markers of current infection in a population of children and adults from Southern Mozambique (N = 715). Antibody responses were measured by quantitative suspension array Luminex technology and their performance was evaluated by ROC curve analysis using microscopic and molecular detection of infections as reference. PRINCIPAL

findingsIgG against the combination of EXP1, AMA1 and MSP2 (P. falciparum) in children and NIE (Strongyloides stercoralis) in adults and children had the highest accuracies (AUC = 0.942 and AUC = 0.872, respectively) as markers of current infection. IgG against the combination of MEA and Sm25 (Schistosoma spp.) were also reliable markers of current infection (AUC = 0.779). In addition, IgG seropositivity against 20 out of the 27 antigens in the panel differentiated the seropositive endemic population from the non-endemic population, suggesting a possible role as markers of exposure although sensitivity could not be assessed.

conclusionsWe provided evidence for the utility of antibody serology to detect current infection with parasites causing tropical diseases in endemic populations. In addition, most of the markers have potential good specificity as markers of exposure. We also showed the feasibility of measuring antibody serology with a platform that allows the integration of control and elimination programs for different pathogens.

Indexed as

HelminthsMalaria, FalciparumAdultAnimalsChildHumansImmunoglobulin GMozambiquePlasmodium falciparumSchistosomaImmunoglobulin G

Identifiers

PMID35727821
PMCPMC9212154
OpenAlexW4283268439

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.